Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

ABSTRACT Due to the urgent need of a therapeutic treatment for coronavirus (CoV) disease 2019 (COVID-19) patients, a number of FDA-approved/repurposed drugs have been suggested as antiviral candidates at clinics, without sufficient information. Furthermore, there have been extensive debates over ant...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Su-Jin Park, Kwang-Min Yu, Young-Il Kim, Se-Mi Kim, Eun-Ha Kim, Seong-Gyu Kim, Eun Ji Kim, Mark Anthony B. Casel, Rare Rollon, Seung-Gyu Jang, Min-Hyeok Lee, Jae-Hyung Chang, Min-Suk Song, Hye Won Jeong, Younho Choi, Weiqiang Chen, Woo-Jin Shin, Jae U. Jung, Young Ki Choi
Format: article
Langue:EN
Publié: American Society for Microbiology 2020
Sujets:
COVID-19
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
antiviral therapeutics
immunosuppression
serum neutralization
ferrets
Microbiology
QR1-502
Accès en ligne:https://doaj.org/article/838b82e09b8e44308365a93fa9f4ed29
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/838b82e09b8e44308365a93fa9f4ed29

Documents similaires